Cruzeiro do Sul Educacional (CSED3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
28 Aug, 2026Executive summary
Net revenue reached BRL 1.4 billion in H1 2025, up 8.8% YoY, driven by expansion in both on-campus and digital student bases.
Adjusted net earnings for H1 2025 were BRL 150 million, up 41.6% YoY, with Q2 2025 at BRL 62.7 million (+1.3% YoY).
Free cash flow to equity surged 121% in H1 2025, converting 64% of EBITDA (ex-IFRS 16) into cash.
Student base grew 13.9% YoY to 585,000, with digital and health segments showing the strongest expansion.
Focused on operational efficiency, disciplined expense management, and course portfolio optimization.
Financial highlights
Adjusted EBITDA for H1 2025 was BRL 452.6 million (+16.8% YoY), with Q2 2025 at BRL 201.3 million (+5.2% YoY); margins were 32.5% and 27.9%, respectively.
Gross profit in Q2 2025 was BRL 365.5 million (+10.9% YoY), with gross margin expanding by 1.5 p.p. in Q2 and 2.1 p.p. in H1 2025.
Net debt/adjusted EBITDA (ex-IFRS 16) was 1.1x at the end of Q2 2025, down from 1.7x a year earlier.
Free cash flow to equity in H1 2025 was BRL 206.5 million, up 121% YoY.
Net debt decreased 21% YoY, with a strong cash position of BRL 656 million at Q2 2025-end.
Outlook and guidance
Management expects continued growth in student base, especially in digital and health segments.
Ongoing focus on operational efficiency, cost discipline, and cash conversion to support investments and dividends.
Investments are aligned with the annual budget, with higher concentration expected in H2 2025.
No explicit cash generation guidance, but management expects positive cash generation in H2 2025, considering seasonality and working capital.
Opportunities identified for further improvement in PDA and ticket pricing, especially in on-campus segment.
Latest events from Cruzeiro do Sul Educacional
- Revenue and net income surged, driven by student growth, digital gains, and FAPI acquisition.CSED3
Q2 2024 - Record free cash flow and net earnings in 3Q24, with strong growth in students and margins.CSED3
Q3 2024 - Record earnings, robust cash flow, and 12% student growth drove strong 2024 results.CSED3
Q4 2024 - Record earnings, margin expansion, and robust cash flow driven by student and health segment growth.CSED3
Q1 2025 - Net income up 82% in 3Q25, with strong digital and health growth and lower leverage.CSED3
Q3 2025 - Record net profit, margin expansion, and robust cash flow highlight strong 2025 performance.CSED3
Q4 2025 - Revenue up 4.5% year-over-year, but net profit down 28.1% amid higher costs and provisions.CSED3
Q1 2026 - Net income rose 61% and adjusted EBITDA margin reached 29.9% on strong healthcare and hybrid growth.CSED3
Q2 2026